Cardiol Therapeutics (CRDL) Current Assets (2020 - 2026)
Cardiol Therapeutics' (CRDL) quarterly Current Assets came in at $22.8 million in Q1 2026, up 29.45% YoY from $17.6 million in Q1 2025, and up 35.29% on a QoQ basis from $16.9 million in Q4 2025.
Cardiol Therapeutics (CRDL) Current Assets (2020 - 2026) Analysis & Trends
Cardiol Therapeutics (CRDL) has 7 years of Current Assets data on file, last reported at $22.8 million in Q1 2026.
- Quarterly Current Assets rose 29.45% year-over-year to $22.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.8 million (up 29.45% YoY) and the FY2025 annual result came in at $16.9 million, down 25.66% from the prior year.
- Current Assets improved to $22.8 million in Q1 2026, from $16.9 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $62.2 million in Q1 2022 to a low of $9.3 million in Q3 2025.
- A 5-year average of $29.8 million and a median of $22.8 million in 2026 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets surged 111.37% — and 2024, when it tumbled 59.99%.
- Tracing CRDL's Current Assets over 5 years: stood at $45.3 million in 2022, then sank by 41.33% to $26.6 million in 2023, then declined by 14.63% to $22.7 million in 2024, then retreated by 25.66% to $16.9 million in 2025, then surged by 35.29% to $22.8 million in 2026.
- The last three Current Assets figures came in at $22.8 million (Q1 2026), $16.9 million (Q4 2025), and $9.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 3.22 Bn |
| 10 | Cardiol Therapeutics | 211.60 Mn | 192.74 Mn | - | 21.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.80 Mn |
| Dec 31, 2025 | 16.85 Mn |
| Sep 30, 2025 | 9.31 Mn |
| Jun 30, 2025 | 14.27 Mn |
| Mar 31, 2025 | 17.61 Mn |
| Dec 31, 2024 | 22.67 Mn |
| Sep 30, 2024 | 12.67 Mn |
| Jun 30, 2024 | 18.92 Mn |
| Mar 31, 2024 | 22.74 Mn |
| Dec 31, 2023 | 26.56 Mn |
| Sep 30, 2023 | 31.66 Mn |
| Jun 30, 2023 | 34.73 Mn |
| Mar 31, 2023 | 38.54 Mn |
| Dec 31, 2022 | 45.26 Mn |
| Sep 30, 2022 | 51.95 Mn |
| Jun 30, 2022 | 57.74 Mn |
| Mar 31, 2022 | 62.16 Mn |
| Dec 31, 2021 | 69.13 Mn |
| Sep 30, 2021 | 24.58 Mn |
| Jun 30, 2021 | 29.22 Mn |